Skip to main content

Day: July 6, 2022

RetinalGeniX Technologies, Inc. Acquires DNA/GPS Inc.

Acquisition of DNA-Based “GPS” Genetic Testing Combines with RTGN’s High Resolution Retinal Imaging Technologies Seeks to Revolutionize Diagnosis of Systemic Diseases PETALUMA, Calif., July 06, 2022 (GLOBE NEWSWIRE) — RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the acquisition of DNA/GPS Inc., a pharmacogenetics company based in Tampa, Florida and founded by Dr. Larry Perich. RetinalGeniX now has the rights to the platform technology designed by Dr. Perich, which allows healthcare providers to use retinal imaging and genetic mapping to monitor and screen patients from their homes to provide diagnoses of systemic diseases including heart disease, Alzheimer’s, dementia, Parkinson’s and more. “We believe this platform to be a breakthrough in advanced retinal...

Continue reading

Global Expansion Continues for Prodege with Acquisition of Germany-based BitBurst

Prodege’s Second Acquisition in 2022 Expands its International Consumer Audience EL SEGUNDO, Calif., July 06, 2022 (GLOBE NEWSWIRE) — Prodege, a cutting-edge marketing and consumer insights platform, announced today that it has acquired BitBurst, a technology-based market research company that connects millions of targeted respondents with surveys every year. This acquisition further expands Prodege’s international supply base and makes it easier for clients to access millions of consumers’ opinions in an agile manner. Founded in 2015, BitBurst’s rapid growth has been driven by its proprietary technology solution which powers its Poll Pay and other apps. BitBurst’s seamless integration provides additional reach for our clients and will provide an immediate incremental benefit for both brands by joining Prodege. “As Prodege...

Continue reading

Extendicare Announces Timing of 2022 Second Quarter Results and Conference Call

MARKHAM, Ontario, July 06, 2022 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the Second quarter of 2022 after market close on Tuesday, August 9, 2022. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Wednesday, August 10, 2022, at 11:30 a.m. (ET) to discuss the results. To participate in the conference call on August 10, 2022, please dial 1-800-319-4610 or 416-915-3239. The conference call and accompanying slide presentation will also be accessible via webcast at www.extendicare.com under the “Our Investors/Events & Presentations” section. A replay of the call will be available approximately two hours after...

Continue reading

Rail Vision Announces First Quarter 2022 Financial Results

RA’ANANA, Israel, July 06, 2022 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), a development stage technology company seeking to revolutionize railway safety and the data-related market, today reported financial results for the first quarter ended March 31, 2022. “The first quarter of 2022 was a truly transformational period for Rail Vision that culminated with our Nasdaq IPO, which provided us with critical funding to accelerate the commercial rollout of our game-changing, artificial-intelligence-driven technology for the rail industry,” said Shahar Hania, CEO of Rail Vision. “I am tremendously proud of the work our team has accomplished in strengthening our foundation for future successes. The results from multiple LTPs underway, nearing completion, and even completed, for major potential...

Continue reading

SLR Investment Corp. Announces Monthly Distribution for July 2022

NEW YORK, July 06, 2022 (GLOBE NEWSWIRE) — SLR Investment Corp. (the “Company”) (NASDAQ: SLRC), today declared a distribution of $0.136667 per share for the month of July 2022. The distribution is payable on August 2, 2022 to stockholders of record as of July 21, 2022. The specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year. ABOUT SLR INVESTMENT CORP. SLR Investment Corp. is a closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. A specialty finance company with expertise in several niche markets, the Company generally invests directly and indirectly in leveraged, U. S. middle market companies primarily in the form of cash flow senior secured loans, including first lien...

Continue reading

Manhattan Associates Announces Date for Reporting Second Quarter 2022 Financial Results

ATLANTA, July 06, 2022 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) today announced it will release its second quarter 2022 financial results on Tuesday, July 26, 2022, after the stock market closes. The press release will be followed by a conference call hosted by Manhattan Associates senior management at 4:30 p.m. Eastern time, also on July 26, 2022. Investors are invited to listen to a live webcast of the conference call through the Investor Relations section of the Manhattan Associates website at ir.manh.com. To listen to the live webcast, please go to the website at least 15 minutes before the call to download and install any necessary audio software. The internet broadcast replay will be available until Manhattan Associates’ third quarter 2022 earnings release. The press release with details on Manhattan’s...

Continue reading

Massey Ferguson Celebrates 175th Anniversary

Iconic Brand Marks Milestone With Renewed Dedication to Farmer-Focused InnovationMassey Ferguson Celebrates 175th Anniversary Massey Ferguson celebrates its 175th anniversary with a renewed dedication to farmer-focused innovation, embodied by the Massey Ferguson 8S Series tractor. The iconic red and gray tractors are recognized across the globe as straightforward, dependable solutions for modern farming operations.DULUTH, Ga., July 06, 2022 (GLOBE NEWSWIRE) — AGCO Corporation (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, proudly celebrates the 175th anniversary of its Massey Ferguson brand. As the first company to sell agricultural products on a global scale, Massey Ferguson has provided straightforward, dependable solutions for generations of...

Continue reading

Atlantic Union Bankshares Corporation To Release Second Quarter 2022 Financial Results

RICHMOND, Va., July 06, 2022 (GLOBE NEWSWIRE) — Atlantic Union Bankshares Corporation (the “Company”) today announced that it will release second quarter 2022 financial results before the market opens on Thursday, July 21, 2022. Following the release, the Company will host a conference call and webcast for analysts at 9:00 a.m. Eastern Time on Thursday, July 21, 2022. Management will conduct a conference call and listen-only webcast with accompanying slides, which can be found at: https://edge.media-server.com/mmc/p/8t2h7c2u. To participate in the call, please register at the following URL: https://register.vevent.com/register/BI251d953edb164e91bd37f98e5106e347. The conference call provider has changed its dial-in procedures, so all attendees must utilize the link to receive an audio dial-in number and their Access PIN. A replay...

Continue reading

The Lancet Gastroenterology & Hepatology Publishes Data from Albireo’s Landmark PEDFIC 1 Study of Bylvay® (odevixibat) Treatment in PFIC

First successful global gold standard pediatric Phase 3 trial ever conducted in cholestatic liver disease PEDFIC 1 & 2 studies were foundational for the approval of Bylvay in the U.S. and Europe Study shows Bylvay provided statistically significant improvements in pruritus severity scores and reductions in serum bile acid levelsBOSTON, July 06, 2022 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced that The Lancet Gastroenterology & Hepatology published the results of the pivotal PEDFIC 1 trial, which evaluated Bylvay® (odevixibat) for the treatment of progressive familial intrahepatic cholestasis (PFIC). The study met both of its two primary endpoints, demonstrating that Bylvay provided statistically significant improvements...

Continue reading

Rogue Station Companies/Everdime, Inc. Acquires Show Homes Business and Intellectual Property

Sheridan, Wyoming, July 06, 2022 (GLOBE NEWSWIRE) — Rogue Station Companies/Everdime, Inc. (OTC Pink: RGST) is pleased to announce that it has executed an agreement with Embeli & Associates to acquire Show Homes, and its intellectual property. The transaction closed July 1, 2022, following completion of due diligence by Everdime to its satisfaction. The transaction is non-dilutive to Everdime shareholders, as consideration for the acquisition is 5 million Everdime tokens when minted.  ShowHomesHub.com aggregates IDX/MLS agents’ listings and in turn displays them beautifully, attracting more potential buyers to the agents’ listings. Buyers can search for agents and other pre-qualified service providers. In addition, DIY property sellers and renters can create a gorgeous listing website to showcase and market their property...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.